Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125755) titled 'Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Care Provider, Outcomes Assessor).
Primary Sponsor: Sun Yat-sen University
Condition:
Squamous Cell Cancer of Head and Neck (SCCHN)
Intervention:
Drug: Cisplatin
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: August 15, 2025
Target Sample Size: 386
Co...